IRIS
BOCCUTO, ADELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.487
EU - Europa 2.462
AS - Asia 1.015
SA - Sud America 216
AF - Africa 71
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.439
RU - Federazione Russa 612
GB - Regno Unito 482
IT - Italia 413
SG - Singapore 310
IE - Irlanda 306
CN - Cina 246
BR - Brasile 186
SE - Svezia 154
FR - Francia 137
DE - Germania 136
HK - Hong Kong 116
VN - Vietnam 109
IN - India 70
FI - Finlandia 54
UA - Ucraina 47
ZA - Sudafrica 35
ES - Italia 34
KR - Corea 28
JP - Giappone 24
TR - Turchia 23
CA - Canada 22
BD - Bangladesh 20
MX - Messico 17
BE - Belgio 16
PL - Polonia 14
NG - Nigeria 13
AR - Argentina 11
NL - Olanda 11
MA - Marocco 10
UZ - Uzbekistan 10
IQ - Iraq 9
IR - Iran 9
AT - Austria 7
CZ - Repubblica Ceca 6
GR - Grecia 6
ID - Indonesia 5
PK - Pakistan 5
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
LV - Lettonia 4
PY - Paraguay 4
RO - Romania 4
CI - Costa d'Avorio 3
JM - Giamaica 3
JO - Giordania 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 6.256
Salva come PNG Salva come JPEG
Città #
Southend 410
Dublin 303
Dallas 299
Fairfield 221
Chandler 198
Moscow 179
Singapore 173
Ashburn 155
Santa Clara 142
San Jose 125
Siena 111
Hong Kong 107
Beijing 99
Seattle 83
Woodbridge 80
Houston 73
Ann Arbor 71
Cambridge 71
Wilmington 61
Princeton 54
New York 53
Munich 52
Council Bluffs 46
Ho Chi Minh City 44
Lauterbourg 41
Jacksonville 39
Los Angeles 39
Milan 38
Johannesburg 34
Helsinki 32
Rome 31
Hefei 29
The Dalles 29
Seoul 25
São Paulo 24
Málaga 22
Bengaluru 21
Boardman 21
Tokyo 20
Hanoi 17
Portsmouth 17
Brussels 16
San Mateo 16
Frankfurt am Main 15
San Diego 15
Orem 14
Abuja 13
Buffalo 13
London 13
Redondo Beach 13
Dearborn 12
Shanghai 12
Düsseldorf 10
Florence 10
Lappeenranta 10
Redwood City 10
Warsaw 10
Brescia 9
Fremont 9
Manchester 9
Nuremberg 9
Turku 9
Mexico City 8
Montreal 8
Nanjing 8
Atlanta 7
Brooklyn 7
Chennai 7
Dong Ket 7
Izmir 7
Paris 7
Rio de Janeiro 7
Roccagorga 7
Tashkent 7
Belo Horizonte 6
Indianapolis 6
Mumbai 6
Naples 6
Phoenix 6
Toronto 6
Vienna 6
Andover 5
Brasília 5
Denver 5
Haiphong 5
North Bergen 5
Perugia 5
Zanjan 5
Amsterdam 4
Bangalore 4
Barnet 4
Cagliari 4
Cairo 4
Changsha 4
Da Nang 4
Draper 4
Istanbul 4
Lancaster 4
Lograto 4
Mooresville 4
Totale 4.148
Salva come PNG Salva come JPEG
Nome #
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 324
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 295
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 293
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 291
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 282
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 252
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 251
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 249
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 246
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 238
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 234
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 232
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 213
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses 211
Novel antiviral strategies against emerging viral diseases 198
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 197
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 179
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 178
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 176
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 174
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 145
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 144
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 137
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 137
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 136
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 135
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis 132
SARS-CoV-2 infection of human ovarian cells: an in vitro model for the detection of the virus entry into the host cells 127
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 125
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 117
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 115
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 107
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 50
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration 41
null 32
Totale 6.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 58 22 36
2021/2022702 26 86 57 88 43 46 43 47 34 57 61 114
2022/2023613 41 98 71 60 46 103 32 38 49 34 25 16
2023/2024521 18 17 48 31 5 147 168 10 0 15 12 50
2024/20251.087 28 40 157 51 110 77 41 90 113 69 110 201
2025/20262.246 150 293 249 348 547 86 256 79 86 152 0 0
Totale 6.393